Literature DB >> 20092981

Stereotactic body radiotherapy: a review.

A Martin1, A Gaya.   

Abstract

Stereotactic body radiotherapy (SBRT) combines the challenge of meeting the stringent dosimetric requirements of stereotactic radiosurgery with that of accounting for the physiological movement of tumour and normal tissue. Here we present an overview of the history and development of SBRT and discuss the radiobiological rationale upon which it is based. The published results of SBRT for lung, liver, pancreas, kidney, prostate and spinal lesions are reviewed and summarised. The current evidence base is appraised and important ongoing trials are identified. Copyright 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20092981     DOI: 10.1016/j.clon.2009.12.003

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  33 in total

1.  Correlation and prediction uncertainties in the cyberknife synchrony respiratory tracking system.

Authors:  Eric W Pepin; Huanmei Wu; Yuenian Zhang; Bryce Lord
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

2.  Estimation of focal and extra-focal radiation profiles based on Gaussian modeling in medical linear accelerators.

Authors:  Shigeo Anai; Hidetaka Arimura; Katsumasa Nakamura; Fujio Araki; Takaomi Matsuki; Hideki Yoshikawa; Satoshi Yoshidome; Yoshiyuki Shioyama; Hiroshi Honda; Nobuo Ikeda
Journal:  Radiol Phys Technol       Date:  2011-03-24

3.  Editorial.

Authors:  Miquel Macià; Carmen Llacer-Moscardo
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-15

4.  Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium.

Authors:  G Distefano; A Baker; A J D Scott; G J Webster
Journal:  Br J Radiol       Date:  2014-03-13       Impact factor: 3.039

5.  A single reference measurement can predict liver tumor motion during respiration.

Authors:  Jakub Cvek; Lukas Knybel; Lukas Molenda; Bretislav Otahal; Tomas Jonszta; Daniel Czerny; David Feltl
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

6.  Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer.

Authors:  Tomas Kron; Brent Chesson; Nicholas Hardcastle; Melissa Crain; Natalie Clements; Mark Burns; David Ball
Journal:  Br J Radiol       Date:  2018-03-06       Impact factor: 3.039

7.  A survey of stereotactic body radiotherapy use in the United States.

Authors:  Hubert Pan; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

8.  Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?

Authors:  S Nahum Goldberg
Journal:  Radiology       Date:  2011-12       Impact factor: 11.105

Review 9.  Cancer concepts and principles: primer for the interventional oncologist-part II.

Authors:  Ryan Hickey; Michael Vouche; Daniel Y Sze; Elias Hohlastos; Jeremy Collins; Todd Schirmang; Khairuddin Memon; Robert K Ryu; Kent Sato; Richard Chen; Ramona Gupta; Scott Resnick; James Carr; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-06-28       Impact factor: 3.464

10.  On the use of AAA and AcurosXB algorithms for three different stereotactic ablative body radiotherapy (SABR) techniques: Volumetric modulated arc therapy (VMAT), intensity modulated radiation therapy (IMRT) and 3D conformal radiotherapy (3D-CRT).

Authors:  Abdulrahman Tajaldeen; Prabhakar Ramachandran; Salem Alghamdi; Moshi Geso
Journal:  Rep Pract Oncol Radiother       Date:  2019-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.